Articles by : Sponsored Content,

SPONSORED CONTENT

The 340B ESP price loading process can be complex. If you’re a covered entity who contracts with outside pharmacies, here’s your guide to navigating 340B ESP, starting with the basics. Equip yourself with these tips to troubleshoot any price loading roadblocks you may encounter, and ensure pricing is loaded

SPONSORED CONTENT

If you are reading this article, then you’re likely aware of the 340B drug discount program, the U.S. federal government program that requires drug manufacturers to provide outpatient drugs to covered entities at significantly reduced prices.

Covered entities may effectively navigate this incredibly complex program, maximize their benefits,

SPONSORED CONTENT

At AllianceRx Walgreens Pharmacy, each covered entity we meet with describes circumstances unique to its hospital, patients, and pharmacy arrangements. The common element for all is the increasing complexity of 340B programming – often changing by the day. Other

SPONSORED CONTENT

In the dynamic world of 340B, identifying and resolving noncompliance issues can be a time-consuming task. Stakeholders can streamline, simplify, and strengthen their 340B operations with solutions from Apexus, which brings together a wealth of knowledge, from credentialing to noncompliance resolution, to help manage a smooth and successful 340B program. Since

SPONSORED CONTENT

Maximizing savings and validating compliance is a necessary process of any 340B entity and not all reporting is the same. Regardless of automatic reporting features, there are many practical reports that use Data Analytics to verify accuracy of data and most importantly, compliance.

SPONSORED CONTENT

For decades, the 340B drug pricing program has served an important purpose by helping hospitals and other covered entities receive discounted prices on drugs to offset care provided to vulnerable, underserved populations.

But over the past several years, drug companies have started pushing back on the 340B